L'Oreal SA
OR: XPAR (FRA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|g> | LOCK|xG | LOCK|%%!^nk^? |
L'Oreal Earnings: Organic Revenue Growth Continues to Accelerate; Shares Marginally Undervalued
L'Oreal posted 7.6% organic revenue growth during the first quarter, its highest rate of growth since the first quarter of 2024. Top-line growth was broad-based across segments, led by double-digit growth in professional products and dermatological beauty. Shares in the US ADR traded 7% higher.
